Blocking a Brain Inflammation Switch Could Open a New Path for Psychiatric Care
Researchers at the University of Birmingham have found that blocking a receptor involved in brain inflammation sharply reduced inflammatory activity in lab-grown brain immune cells and in human brain tissue. Because inflammation is thought to play a role in conditions including depression and psychosis as well as neurodegenerative illness, the team says existing drugs that block this receptor could be worth testing in future clinical trials, though this work is still at the laboratory stage.
Source: ScienceDaily
Texas Clinic Shortens Brain Stimulation Sessions and Adds Care for OCD
UT Health RGV has expanded its noninvasive brain stimulation program, cutting typical sessions from about 45 minutes to roughly 15 to 20 minutes and offering accelerated schedules with several sessions in a day. The program has also added a protocol for obsessive-compulsive disorder, giving people whose symptoms have not improved enough with standard care another option, and the clinic says shorter visits may make a multi-week course easier to fit around work and family life.
Source: University of Texas Rio Grande Valley
UN Expert Says Everyday Discrimination Is Taking a Lasting Toll on People With Albinism
A United Nations independent expert has told the General Assembly that people with albinism face daily colour-based discrimination that limits access to health care, education, work and public life and harms their sense of safety and belonging. The report links that ongoing exclusion to anxiety, depression, low self-esteem and isolation, and calls for legal and policy reforms that address both the prejudice itself and its psychological and social effects.
Source: Devdiscourse
Researchers at the University of Birmingham have found that blocking a receptor involved in brain inflammation sharply reduced inflammatory activity in lab-grown brain immune cells and in human brain tissue. Because inflammation is thought to play a role in conditions including depression and psychosis as well as neurodegenerative illness, the team says existing drugs that block this receptor could be worth testing in future clinical trials, though this work is still at the laboratory stage.
Source: ScienceDaily
Texas Clinic Shortens Brain Stimulation Sessions and Adds Care for OCD
UT Health RGV has expanded its noninvasive brain stimulation program, cutting typical sessions from about 45 minutes to roughly 15 to 20 minutes and offering accelerated schedules with several sessions in a day. The program has also added a protocol for obsessive-compulsive disorder, giving people whose symptoms have not improved enough with standard care another option, and the clinic says shorter visits may make a multi-week course easier to fit around work and family life.
Source: University of Texas Rio Grande Valley
UN Expert Says Everyday Discrimination Is Taking a Lasting Toll on People With Albinism
A United Nations independent expert has told the General Assembly that people with albinism face daily colour-based discrimination that limits access to health care, education, work and public life and harms their sense of safety and belonging. The report links that ongoing exclusion to anxiety, depression, low self-esteem and isolation, and calls for legal and policy reforms that address both the prejudice itself and its psychological and social effects.
Source: Devdiscourse